Although extended studies regarding the expression pattern in additional tumors of relevance for differential diagnostics, e.g. adrenal gland tumors and other forms of clear cell cancer, are required to establish the usefulness of CUBN staining in clinical routine, the presented results indicate that this marker could be used for difficult cases where a diagnosis of RCC needs to be confirmed. This evidence concerns the gene CUBN and adrenal gland neoplasm.